Lotus KFM Berhad (KLSE:LOTUS)

Regulus Therapeutics Revenue

Lotus KFM Berhad had revenue of 12.98M MYR in the quarter ending March 31, 2025, with 2.80% growth. This brings the company's revenue in the last twelve months to 51.98M, up 1.85% year-over-year. In the fiscal year ending September 30, 2024, Lotus KFM Berhad had annual revenue of 50.70M, down -13.34%.

• Revenue (ttm): 51.98M
• Revenue Growth: +1.85%
• P/S Ratio: 2.96
• Revenue / Employee: 259.92K
• Employees: 200
• Market Cap: 154.00M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2024	50.70M	-7.81M	-13.34%
Sep 30, 2023	58.51M	-7.57M	-11.46%
Sep 30, 2022	66.08M	14.32M	27.66%
Sep 30, 2021	51.76M	-3.34M	-6.05%
Sep 30, 2020	55.10M	-2.80M	-4.83%